PLSE EBITDA Growth
Pulse Biosciences Inc · EBITDA Growth
PLSE EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-19.00%period ending
PLSE TTM EBITDA YoY % (-199.50% → -19.00%)
Year-over-year change
High-resolution chart · PNG
PLSE ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -19.0011% | |
| -25.4092% | |
| -36.8329% | |
| -63.8569% | |
| -56.218% | |
| -42.9079% | |
| -30.3559% | |
| -21.5099% | |
| 3.5652% | |
| 14.6461% | |
| 29.0752% | |
| 41.6561% | |
| 25.6098% | |
| 20.033% | |
| 8.3791% | |
| -5.252% | |
| -1.3706% | |
| -9.2631% | |
| -26.5971% | |
| -22.7578% | |
| -22.3501% | |
| -14.5541% | |
| -4.4387% | |
| -17.2114% | |
| -18.252% | |
| -26.2543% | |
| -27.6649% | |
| -14.8155% | |
| -22.8811% | |
| -27.0392% | |
| -47.7169% | |
| -92.4762% | |
| -131.0359% | |
| -190.7488% | |
| -181.1353% | |
| -151.7959% | |
| -140.0784% | |
| -121.7324% | |
| -135.2994% | |
| -199.5047% |